Ambergen, Inc. announced that it will issue 45,914 series C preferred shares at an issue price of $108.899246 per share for the gross proceeds of $4,999,999.980844 on March 22, 2022. The preferred shares will be convertible into common shares at a fixed conversion price $108.89924 per share. The company will issue securities pursuant to exemption provided under Regulation D. The minimum investment accepted from any outside investor is $5,000,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.09 USD | -11.31% | -13.03% | -4.61% |
05-02 | Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance | MT |
05-02 | Earnings Flash (BRKR) BRUKER CORPORATION Posts Q1 Revenue $721.7M, vs. Street Est of $729M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.61% | 10.19B | |
+7.62% | 218B | |
+6.70% | 183B | |
+11.94% | 134B | |
+24.60% | 106B | |
-1.52% | 61.12B | |
+4.81% | 50.89B | |
+11.55% | 51.26B | |
-1.09% | 40.3B | |
+26.82% | 32.05B |
- Stock Market
- Equities
- BRKR Stock
- News Bruker Corporation
- AmberGen, Inc. announced that it expects to receive $5 million in funding